Houston, TX – 05/23/2019. DermaClip® is pleased to announce the publishing of its second peer reviewed article in the United States. The article by Dr. Robert J. Rubino, M.D., FACOG, and Dr. Charbel G. Salamon, M.D., FACOG, FACS, was published in the Journal of Reproductive Medicine and titled “Evaluation of a Novel Skin Closure Device at the Time of Cesarean Section: A Randomized Pilot Study.” The article compares the DermaClip non-invasive skin closure device to subcuticular skin closure for C-Section closures, a study completed by Drs. Rubino and Salamon, and their teams, at Saint Barnabas Medical Center in New Jersey.
Abstract (as published by The Journal of Reproductive Medicine)
Authors: Robert J. Rubino, M.D., FACOG, and Charbel G. Salamon, M.D., FACOG, FACS
OBJECTIVE: To compare the DermaClip non-invasive skin closure device to subcuticular skin closure at the time of cesarean delivery.
STUDY DESIGN: This was a prospective randomized pilot study of 32 patients undergoing cesarean section. All patients signed an institutional review board–approved informed consent to participate in the study. The primary outcome was operative time for the skin closure.
RESULTS: A total of 32 patients met the inclusion and exclusion criteria and were randomized. There was no difference in age, race, or body mass index (BMI). The median age in both groups was 34.5 years, and the mean BMIs were 33.2 kg/m2 and 32.7 kg/m2 in the DermaClip and subcuticular groups, respectively (p= 0.776). As to the primary outcome, skin closure time, DermaClip allowed for a significantly faster closure time at 3 minutes, 15 seconds versus 6 minutes, 57 seconds (p<0.0001).
CONCLUSION: The DermaClip closure time was significantly faster than the subcuticular suture closure by 3 minutes and 7 seconds. Future studies that are adequately powered to compare wound separation, infections, and dehiscence are needed to fully evaluate this novel closure device and its potential role in cesarean delivery wound closure.
Read the full article.
DermaClip® aims to optimize incision, laceration and wound repair through non-invasive, cost-effective and efficiency-producing skin closure devices. DermaClip is a non-invasive skin closure device that is an alternative to sutures, surgical staples and glues. The device aims to improve the patient experience while reducing the time and cost burden of closure by transforming a highly variable skill into a reproducible process. The device has been used in more than 30,000 cases, everywhere from in the field to the Emergency Department to the surgical suite. The DermaClip team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care. DermaClip is headquartered in Houston, TX. For more information, visit the DermaClip website. You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.